DrugPatentWatch Database Preview

Details for Patent: 8,530,694

Which drugs does patent 8,530,694 protect, and when does it expire?

Patent 8,530,694 protects NINLARO and is included in one NDA.

This patent has fifty-four patent family members in thirty-four countries.

Summary for Patent: 8,530,694

Title:	Proteasome inhibitors
Abstract:	The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
Inventor(s):	Olhava; Edward J. (Newton, MA), Danca; Mihaela Diana (Mendham, NJ)
Assignee:	Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:	13/209,511
Patent Claim Types: see list of patent claims	Compound; Composition; Use;

Drugs Protected by US Patent 8,530,694

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Millennium Pharms	NINLARO	ixazomib citrate	CAPSULE;ORAL	208462-001	Nov 20, 2015		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y	Y		METHOD FOR TREATING CANCER, INCLUDING MULTIPLE MYELOMA	➤ Sign Up
Millennium Pharms	NINLARO	ixazomib citrate	CAPSULE;ORAL	208462-002	Nov 20, 2015		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y	Y		METHOD FOR TREATING CANCER, INCLUDING MULTIPLE MYELOMA	➤ Sign Up
Millennium Pharms	NINLARO	ixazomib citrate	CAPSULE;ORAL	208462-003	Nov 20, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y	Y		METHOD FOR TREATING CANCER, INCLUDING MULTIPLE MYELOMA	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 8,530,694

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
8,003,819	Proteasome inhibitors	➤ Sign Up
8,772,536	Proteasome inhibitors	➤ Sign Up
8,871,745	Proteasome inhibitors	➤ Sign Up
7,442,830	Proteasome inhibitors	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Patents Family Members for US Patent 8,530,694

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	067824	➤ Sign Up
Australia	2007357338	➤ Sign Up
Brazil	PI0721905	➤ Sign Up
Canada	2695082	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,530,694

For more information try a trial or see the plans and pricing